Related Experiment Video
Updated: Jul 25, 2026
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Retrospective Evaluation of Hematological Parameters in COVID-19 Patients: Insights From the Emergency Department
1College of Applied Medical Sciences, Jazan University, Jazan, SAU.
Insights
Neutrophil percentage and count are significantly associated with COVID-19 outcomes, offering potential for improved patient care. This finding aids in understanding the clinical impact of hematological parameters in coronavirus disease 2019.
Area of Science:
- Hematology
- Infectious Diseases
- Clinical Medicine
Background:
- Retrospective analysis of hematological parameters in COVID-19 patients.
- Focus on clinical insights and patient outcomes.
Purpose of the Study:
- To evaluate hematological parameters in COVID-19 patients.
- To identify associations between these parameters and disease outcomes.
Main Methods:
- Data collected from Samtah General Hospital, Saudi Arabia (April 2020 - October 2021).
- Analysis of 153 participants, including 23 deceased.
- Chi-square and Cox regression analyses were performed.
Main Results:
- No significant associations found between sex, BMI, age, and COVID-19 outcome.
- Significant association observed between neutrophil percentage and disease outcome.
- Neutrophil count significantly associated with survival outcomes (P=0.030).
Conclusions:
- Hematological parameters, particularly neutrophil levels, show potential for predicting COVID-19 outcomes.
- Integration into clinical guidelines can enhance patient care and decision-making.
Background:
This retrospective study evaluated hematological parameters in coronavirus disease 2019 (COVID-19) patients to gain clinical insights.
Methods:
Data from the Emergency Department of Samtah General Hospital, Samtah, Saudi Arabia, were analyzed, focusing on the parameters measured during hospital admission. This study was conducted between April 2020 and October 2021. Associations between hematological parameters and COVID-19 outcomes were examined in 153 participants, including 23 deceased individuals.
Results:
The chi-square test results indicated no significant associations (P >0.05) between sex, body mass index (BMI), age, and disease outcome in the study population. However, a significant association was observed between neutrophil percentage and disease outcome, whereas no significant associations were found for red blood cell count, hemoglobin level, monocyte percentage, eosinophil percentage, and basophil percentage. Cox regression analysis revealed a significant association between neutrophil count (considered a categorical covariate) and survival outcomes (P = 0.030). However, specific neutrophil categories (50-70 and >70) were not significantly associated with survival.
Conclusions:
Integrating hematological parameters into COVID-19 clinical guidelines and decision-support tools holds promise for enhancing patient care and outcomes.
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
05:58Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes
Published on: March 22, 2022
Related Concept Videos
02:45Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:15Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
01:26Blood Studies I: ABG and VBG
Arterial Blood Gas (ABG)
Arterial Blood Gas (ABG) studies are crucial for assessing the lungs' ability to supply oxygen and remove carbon dioxide, reflecting the patient's ventilation status. They also help understand the kidneys' capacity to reabsorb or...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:30Acute Coronary Syndrome III: Diagnostic Studies